Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-26

Clinical Trial Update: A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting results from multiple dosing regimens of IV conivaptan in patients with euvolemic or hypervolemic hyponatremia, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Conivaptan (conivaptan)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Hyponatremia, Euvolemia | Phase 4 | Status: COMPLETED | Results posted: 2010-05-26